DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 15897555)

Published in Clin Cancer Res on May 15, 2005

Authors

Justis P Ehlers1, Lori Worley, Michael D Onken, J William Harbour

Author Affiliations

1: Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.

Articles citing this

Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer (2010) 3.59

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell (2011) 2.30

Susceptibility to tuberculosis is associated with variants in the ASAP1 gene encoding a regulator of dendritic cell migration. Nat Genet (2015) 1.66

Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data. Nucleic Acids Res (2008) 1.52

Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol (2007) 1.48

Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol (2008) 1.44

Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum. J Nat Prod (2007) 1.44

The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res (2012) 1.39

The EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer invasion and metastasis. Traffic (2009) 1.31

The spatial repositioning of adipogenesis genes is correlated with their expression status in a porcine mesenchymal stem cell adipogenesis model system. Chromosoma (2009) 1.20

Kinetic analysis of GTP hydrolysis catalysed by the Arf1-GTP-ASAP1 complex. Biochem J (2007) 1.14

CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J (2007) 1.14

ASAP3 is a focal adhesion-associated Arf GAP that functions in cell migration and invasion. J Biol Chem (2008) 1.12

Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol (2009) 1.07

Smardaesidins A-G, isopimarane and 20-nor-isopimarane diterpenoids from Smardaea sp., a fungal endophyte of the moss Ceratodon purpureus. J Nat Prod (2011) 0.98

Molecular pathology of uveal melanoma. Eye (Lond) (2012) 0.94

Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer. Clin Exp Metastasis (2008) 0.94

Dynamic interaction between Arf GAP and PH domains of ASAP1 in the regulation of GAP activity. Cell Signal (2008) 0.94

Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization. Virchows Arch (2006) 0.91

Arf GTPase-activating protein AGAP2 regulates focal adhesion kinase activity and focal adhesion remodeling. J Biol Chem (2009) 0.88

A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation. Oncotarget (2015) 0.87

Eye cancer: unique insights into oncogenesis: the Cogan Lecture. Invest Ophthalmol Vis Sci (2006) 0.86

Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma. Mol Vis (2009) 0.81

Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer. Int J Clin Exp Pathol (2013) 0.80

Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract (2010) 0.80

Upcoming translational challenges for uveal melanoma. Br J Cancer (2015) 0.78

Drosophila as a Potential Model for Ocular Tumors. Ocul Oncol Pathol (2015) 0.77

Allosteric properties of PH domains in Arf regulatory proteins. Cell Logist (2016) 0.76

Arf proteins in cancer cell migration. Small GTPases (2016) 0.75

No Significant Effect of ASAP1 Gene Variants on the Susceptibility to Tuberculosis in Chinese Population. Medicine (Baltimore) (2016) 0.75

Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma. Sci Rep (2016) 0.75

ArfGAPs: key regulators for receptor sorting. Receptors Clin Investig (2014) 0.75

Arf GTPase-activating proteins and their potential role in cell migration and invasion. Cell Adh Migr (2008) 0.75

The biology of uveal melanoma. Cancer Metastasis Rev (2017) 0.75

[Ocular melanomas : An update]. Pathologe (2017) 0.75

Articles by these authors

Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47

Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83

Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14

Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res (2011) 2.54

An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn (2010) 2.48

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet (2013) 2.20

Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res (2007) 2.15

Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist (2011) 2.05

Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res (2006) 2.03

MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol (2004) 1.89

Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res (2007) 1.71

Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol (2003) 1.67

Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res (2008) 1.54

Risk factors for metastasis in retinoblastoma. Surv Ophthalmol (2002) 1.49

Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol (2008) 1.44

Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab (2013) 1.42

Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res (2008) 1.36

A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res (2008) 1.26

Transducible peptide therapy for uveal melanoma and retinoblastoma. Arch Ophthalmol (2002) 1.20

Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens. J Mol Diagn (2006) 1.20

Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Ophthalmol (2005) 1.19

Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res (2008) 1.18

Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol (2014) 1.13

Patient-derived xenografts recapitulate molecular features of human uveal melanomas. Mol Oncol (2013) 1.11

Fine needle aspiration biopsy with adjunct immunohistochemistry in intraocular tumor management. Acta Cytol (2005) 1.10

Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. Invest Ophthalmol Vis Sci (2005) 1.08

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer (2013) 1.04

Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina (2011) 1.03

Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res (2012) 1.01

Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol (2012) 1.01

Molecular genetics of uveal melanoma. Curr Eye Res (2003) 1.00

Rb at the interface between cell cycle and apoptotic decisions. Curr Mol Med (2006) 0.98

Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina (2014) 0.98

Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J Biol Chem (2003) 0.97

NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res (2005) 0.95

Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization. Arch Ophthalmol (2009) 0.93

Optical coherence tomography in the evaluation of retinal changes associated with suspicious choroidal melanocytic tumors. Am J Ophthalmol (2004) 0.92

Review of 676 second primary tumors in patients with retinoblastoma: association between age at onset and tumor type. Arch Ophthalmol (2010) 0.92

Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am J Roentgenol (2008) 0.90

ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity. Pigment Cell Melanoma Res (2011) 0.90

Lipid exudation following plaque radiotherapy for posterior uveal melanoma. Am J Ophthalmol (2006) 0.88

Association between gene expression profile, proliferation and metastasis in uveal melanoma. Curr Eye Res (2010) 0.87

Tilting of radioactive plaques after initial accurate placement for treatment of uveal melanoma. Arch Ophthalmol (2008) 0.87

For whom the bell tolls: susceptibility to common adult cancers in retinoblastoma survivors. J Natl Cancer Inst (2004) 0.85

Pars plana vitrectomy in eyes containing a treated posterior uveal melanoma. Am J Ophthalmol (2003) 0.85

Cytologic diagnosis of intraocular lymphoma in vitreous aspirates. Acta Cytol (2004) 0.85

A role for Jag2 in promoting uveal melanoma dissemination and growth. Invest Ophthalmol Vis Sci (2013) 0.83

High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.82

Molecular pathobiology of uveal melanoma. Int Ophthalmol Clin (2006) 0.82

Multimodal imaging of sarcoid choroidal granulomas. J Ophthalmic Inflamm Infect (2013) 0.81

Inhibiting angiogenesis in retinoblastoma. Ophthalmic Res (2007) 0.80

Correlation study of benign cytomorphology and final clinical diagnosis. Acta Cytol (2008) 0.80

Id2 deficiency promotes metastasis in a mouse model of ocular cancer. Clin Exp Metastasis (2010) 0.80

Uveal melanoma: genetic aspects. Ophthalmol Clin North Am (2005) 0.79

Gene expression profiling versus TNM classification. Ophthalmology (2013) 0.79

Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase. J Biol Chem (2005) 0.79

Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma. Curr Eye Res (2010) 0.78

Status of the NF1 tumor suppressor locus in uveal melanoma. Arch Ophthalmol (2003) 0.78

Gene expression profiling and regression rate of irradiated uveal melanomas. Ophthalmic Surg Lasers Imaging Retina (2015) 0.78

Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism. Graefes Arch Clin Exp Ophthalmol (2014) 0.77

Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction. J Clin Invest (2013) 0.77

Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy. Am J Ophthalmol (2002) 0.77

Molecular prognostic testing in uveal melanoma: has it finally come of age? Arch Ophthalmol (2007) 0.76

Photodynamic therapy for circumscribed choroidal hemangioma. Can J Ophthalmol (2002) 0.75

Gene expressing profiling of iris melanomas. Ophthalmology (2013) 0.75

Author reply: To PMID 22521086. Ophthalmology (2013) 0.75

Molecular testing prognostic of low risk in epithelioid uveal melanoma in a child. Br J Ophthalmol (2013) 0.75

Comment on "Lowpenetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras" by Park et al. Cell Cycle (2008) 0.75

What is the best treatment for retinoblastoma? Am J Ophthalmol (2004) 0.75

Spectral-Domain Optical Coherence Tomography of Presumed Solitary Circumscribed Retinal Astrocytic Proliferation Versus Astrocytic Hamartoma. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75

A transformation in ocular oncology: from megacenter to multicenter. Arch Ophthalmol (2010) 0.75

Uveal and Conjunctival Melanoma: Close Together-but Only Distantly Related. Oncology (Williston Park) (2016) 0.75

Preclinical Acute Ocular Safety Study of Combined Intravitreal Carboplatin and Etoposide Phosphate for Retinoblastoma. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature. Melanoma Res (2016) 0.75

Multimodal Imaging of Astrocytic Hamartomas Associated With Tuberous Sclerosis. Ophthalmic Surg Lasers Imaging Retina (2017) 0.75